#BIO In the Web3 space, the DeSci life sciences sector is attracting widespread attention from industry insiders. Currently, projects in this field are mainly focused on biology and medicine, with the $BIO ecosystem playing a significant role.

However, life science projects require a complex series of processes from experimentation to practical application, including clinical testing, approval, and regulation. This inevitably consumes a significant amount of time and funds, leading to a considerable degree of uncertainty regarding the success of the project.

From the nature of the projects, they can be divided into three main categories: scientific research, engineering development, and practical application. Scientific and engineering projects are usually conducted in universities, research institutes, or large enterprises, characterized by long cycles and significant investments, but it is difficult to see obvious results in the short term. In contrast, application projects are more grounded; they directly develop products or provide services using existing research results, making it easier to generate benefits in the short term. This also explains why past ICOs, IEOs, and IDOs were able to quickly become popular, as many application projects could rapidly go live and operate, resulting in significant wealth effects.

Currently, leading industry projects like Bio are trying to build financing platforms in hopes of promoting the development of the entire ecosystem. Such attempts can indeed trigger a wave of enthusiasm in the short term, driving up token prices. However, if there are no substantial developments afterward, the excitement will eventually fade.

For the DeSci track, a wise investment strategy is to maintain continuous follow and participate in projects of interest on a small scale. Although this field is currently full of uncertainty, it is precisely this uncertainty that may nurture huge potential returns. After all, in financial markets, high risk often accompanies high returns.

Overall, the DeSci life sciences track represents the cutting-edge integration of technology and finance. It faces challenges in both technology and regulation, but also holds great potential to transform the future of healthcare. Investors need to find a balance between opportunities and risks, remaining cautious while not missing out on possible breakthrough developments.